LONG-TERM CONSEQUENCES OF HEPATITIS A IN CHILDREN
https://doi.org/10.22627/2072-8107-2014-13-3-54-61
Abstract
Various embodiments of lingering forms of hepatitis A, for the aggravation still cause differential diagnostic difficulties and mistakes. Continuing to the present heavy and cholestasis form of hepatitis A in children, fulminant form of adolescents, adults and pregnant women let to suggest this issue to be relevance. The task of vaccine prevention of hepatitis A in the National Immunization ScheduleRussiakeeping up to be relevance and perspective. Numerous studies have shown that the French vaccine AVAXIM 80 showed good immunogenicity and safety vaccinate in children.
About the Authors
V. F. Uchaikin
Russian National Research Medical University after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
O. V. Kovalev
Russian National Research Medical University after N.I. Pirogov, Moscow
Russian Federation
Kovalev Oleg — DMS, Professor of Department of Infectious Diseases in Children of Russian National Research Medical University after N.I. Pirogov Russian Ministry of Health; Shmitovskiy proezd, 29, CMCH №9, Moscow, 123317, Russia; (499) 256-60-26
Russian Federation
Kovalev Oleg — DMS, Professor of Department of Infectious Diseases in Children of Russian National Research Medical University after N.I. Pirogov Russian Ministry of Health; Shmitovskiy proezd, 29, CMCH №9, Moscow, 123317, Russia; (499) 256-60-26
O. V. Molochkova
Russian National Research Medical University after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
T. V. Cherednychenko
Russian National Research Medical University after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
References
1. Учайкин В.Ф., Нисевич Н.И., Шамшева О.В. Инфекционные болезни и вакцинопрофилактика у детей. — М.: Гэотар Медицина, 2006. — 687 с. Uchaykin V.F., Nisevich N.I., Shamsheva O .V. Infektsionnyie bolezni i vaktsinoprofilaktika u detey [Infectious diseases and vaccination in children].— M.: Geotar Meditsina, 2006. — 687 s.
2. Учайкин В.Ф., Нисевич Н.И., Чередниченко Т.В. Вирусные гепатиты от А до TTV. — Москва, 2003. — 431 с. Uchaykin V.F., Nisevich N.I., Cherednichenko T.V. Virusnyie gepatityi ot A do TTV [Viral hepatitis A to TTV]. — Moskva, 2003. — 431 s. (In Russ).
3. Sherlock S., Dooley J. Diseases of the liver and biliary system. — 10th ed. London: Blackwell Science Ltd., 1997. — 400 p.
4. Майер К-П. Гепатит и последствия гепатита. Практическое руководство /Пер. с нем.; под ред. А.А. Шептулина. — М.: Гэотар Медицина, 1999. — 432 с. Mayer K-P. Gepatit i posledstviya gepatita. Prakticheskoe rukovodstvo [Hepatitis and effects of hepatitis. A Practical Guide]. — pod red A.A .Sheptulina. — M.: Geotar Meditsina, 1999. — 432 s. (In Russ).
5. Учайкин В.Ф., Чередниченко Т.В., Ковалев О.Б. Клиническое течение, отдаленные последствия и исходы гепатита А у детей // Педиатрическая фармакология. — 2009. — Т. 6, № 3. — С. 7—12. Uchaykin V.F., Cherednichenko, Kovalev O.B. Klinicheskoe techenie, otdalennyie posledstviya i ishodyi gepatita A u detey [The clinical course, long-term consequences and outcomes of hepatitis A in children] // Pediatricheskaya Farmakologiya [Pediatric Pharmacology] . 2009. T.6, № 3. S.7—12. (In Russ).
6. Нисевич Н.И., Марчук Г.И., Зубикова И.И. и др. Математическое моделирование вирусного гепатита. — М.: Наука, 1981. — 352 с. Nisevich N.I., Marchuk G.I., Zubikova I.I. dr. Matematicheskoe modelirovanie virusnogo gepatita [Mathematical modeling of viral hepatitis]. — M. Nauka. — 1981. — 352 s. (In Russ).
7. Учайкин В.Ф., Шамшева О.В. Руководство по клинической вакцинологии. — М.: Гэотар Медицина, 2006. — 455 с. Uchaykin V.F., Shamsheva O.V. Rukovodstvo po klinicheskoy vaktsinologii [Manual of Clinical Vaccinology]. — M.: Geotar Meditsina. — 2006. — 455 s. (In Russ).
8. Таточенко В.К., Озерецковский Н.А., Федоров А.М. Иммунопрофилактика — 2009 (Справочник). — М., 2009. — 176 с. V.K.Tatochenko, N.A.Ozeretskovskiy, A.M.Fedorov. Immunoprofilaktika — 2009 (Spravochnik).[ Immunization 2009 (Reference)]. — M., 2009. — 176 s. (In Russ).
9. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children / K. Abarca, I. Iba´nez, C. Perret, P. Vial, J.—A. Zinsou // International Journal of Infectious Diseases. — 2008. — 12. — Р. 270—277.
10. An Open, Prospective, Randomized Study Comparing the Immunogenicity and Safety of Two Inactivated Hepatitis A Pediatric Vaccines in Toddlers, Children and Adolescents in China / Rong Cheng Li et all. // Pediatr Infect Dis J. — 2013; 32 : e77—e81.
11. Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine Given with Measles-Mumps-Rubella Vaccine to 12—13 Month Old Turkish Children / Yurdako(ö)k et all. // J Vaccines Vaccin. — 2012. — V. 3 : Is. 5.
12. Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina / C. Espul et all. // Hepatic Medicine: Evidence and Research, 27 августа 2012.
13. Decline in HAVassociated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program / G. Cervio et all. // Hepatic Medicine: Evidence and Research. 16 сентября 2011.
14. Кюрегян К.К., Михайлов М.И. Массовая вакцинация против гепатита А с использованием одной дозы вакцины — опыт Аргентины // В мире вирусных гепатитов. — 2 (2013). — С. 13—18. Massovaya vaktsinatsiya protiv gepatita A s ispolzovaniem odnoy dozyi vaktsinyi — opyit Argentinyi [Mass vaccination against hepatitis A with a single dose of vaccine — the experience of Argentina] / K.K. Kyuregyan, M.I. Mihaylov // V Mire Virusnyih Gepatitov [In the World of viral hepatitis]. — №2 (2013). — S. 13—18. (In Russ).
15. Кюрегян К.К., Михайлов М.И. Взаимозаменяемость инктивированных вакцин против гепатита А // В мире вирусных гепатитов. — 3 (2013). — С. 8—11. Vzaimozamenyaemost inktivirovannyih vaktsin protiv gepatita A [Interchangeability inktivirovannyh hepatitis A vaccines ] / K.K. Kyuregyan, M.I. Mihaylov // V Mire Virusnyih Gepatitov [In the World of viral hepatitis]. — №3, 2013. — S. 8—11. (In Russ).
16. Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey / A. Soysal, I. Gokçe, T. Pehlivan, M. Bakir // Eur J Pediatr. — 2007. — 166 : 533—539.
Review
For citations:
Uchaikin V.F., Kovalev O.V., Molochkova O.V., Cherednychenko T.V. LONG-TERM CONSEQUENCES OF HEPATITIS A IN CHILDREN. CHILDREN INFECTIONS. 2014;13(3):54-61. (In Russ.) https://doi.org/10.22627/2072-8107-2014-13-3-54-61
Views:
787
Email this article 